DiaSys Showcases Expanding Reagents and Instrumentation Portfolio at AACC 2022

DiaSys Diagnostic Systems (Holzheim, Germany) is showcasing its expanding product portfolio of analyzers and POCT instruments with a special focus on its reagents, at the 73rd AACC Annual Scientific Meeting & Clinical Lab Expo. Vidan Diagnostics (San Antonio, TX, USA), in partnership with Diasys, is also attending the event where it will feature the recently launched next generation Beta-hydroxybutyrate assay used to assist in the determination of diabetic ketoacidosis (DKA).

At the DiaSys AACC 2022 booth, the focus will be on the company’s reagents HDL-c direct FS, LDL-c direct FS, Cystatin C FS, Procalcitonin FS and CRP FS. The company’s innovative new reagents, HDL-c direct FS and LDL-c direct FS, are homogenous assays for direct determination of high-density lipoproteins (HDL) and low-density lipoproteins (LDL). The high quality reagents offer long calibration and onboard stability of up to four months. Combined with wide measuring ranges and good precision at clinical cut-off points, DiaSys assays HDL-c direct FS and LDL-c direct FS are of high value for clinical-chemistry laboratories.

DiaSys Cystatin C FS is an immunturbidemetric assay, which can be applied on a broad range of clinical chemistry analyzers. The assay is characterized by an outstanding analytical sensitivity in addition to superior correlation with nephelometry. It has excellent onboard and calibration stabilities up to 12 weeks and a high prozone security. The standardized test is essential for reliable kidney diagnosis of clinical-chemistry laboratories.

DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay with outstanding onboard and calibration stability, providing a convenient workflow on clinical chemistry analyzers. Determinations of PCT in serum and plasma within the measuring range from 0.2 ng/mL to 50 ng/mL can be performed with high precision at clinical cut-off levels for sepsis. The performance is complemented by high tolerance to endogenous interferents and various therapeutics used in sepsis management. Procalcitonin FS shows a good correlation to established methods. Results from ring trials and a publication demonstrate the strengths of the assay.

DiaSys CRP FS is a liquid-stable immunoturbidimetric test with dedicated ready-to-use calibrators and controls. The test results are fully quantitative which allows true differentiation of borderline cases. The test is standardized to the international reference material, has a wide measuring range, high prozone security and excellent correlation to competitor tests. The test is easily applicable to clinical chemistry analyzers with a variety of instrument applications available.

Additionally, DiaSys will demonstrate the respons 940 fully automatic random access analyzer (RAM) with a sample throughput of 400 (640 incl. ISE) tests/hour. Due to durable quartz cuvettes, low reaction volume, maintenance free photometer and intuitively operated software, respons 940 offers the economic use and reliability required in small to medium sized labs. In combination with DiaSys' high quality reagents perfectly matching to respons 940 highest results security and therefore, a minimized number of reruns can be assured.

Vidan’s next generation Beta-hydroxybutyrate assay for reliable ketosis management comprises prefilled reagent kits that make it easy to load directly onto Architect and Beckman AU clinical chemistry systems. Its Lipid Clearing System (LCS) overcomes the burden of lipemia by eliminating turbidity in the sample before a measurement is performed. Its superior stability reduces the frequency of calibration and allows the reagent to stay onboard longer.
 

Related Links:
DiaSys Diagnostic Systems 
Vidan Diagnostics 

Visit expo >

Gold Member

Turnkey Packaging Solution

HLX

Automated Blood Typing System
IH-500 NEXT

New

Vitamin B12 Test

CHORUS CLIA VIT B12

New

PSA Test

Human Semen Rapid Test